H Yu

Clinical Observation of Docetaxel or Gemcitabine Combined with Cisplatin in the Chemotherapy after Surgery for Stage II-III Non-small Cell Lung Cancer

DOI:

10.7727/wimj.2015.125

Synopsis:

Chemotherapy is an important part of combined therapy for non-small cell lung cancer and can enhance the survival rate of patients subjected to surgery. This study aimed to compare the efficacy and toxicity of docetaxel combined with cisplatin (DP) and gemcitabine combined with cisplatin (GP) in postoperative chemotherapy after surgery of non-small cell lung cancer NSCLC.

ABSTRACT

Objective: This study aimed to compare the efficacy and toxicity of docetaxel combined with cisplatin (DP) and gemcitabine combined with cisplatin (GP) in postoperative chemotherapy after surgery of non-small cell lung cancer (NSCLC).

Received:

04 Jun, 2015

Accepted:

02 Mar, 2015

PDF Attachment:

chen20et20al-chemotherapy20for20stage20ii-iii20non-small20cell20lung20cancer2.pdf

Journal Sections:

Keywords:

Postoperative chemotherapy

Journal Authors:

e-Published: 18 Nov, 2015

Read more about Clinical Observation of Docetaxel or Gemcitabine Combined with Cisplatin in the Chemotherapy after Surgery for Stage II-III Non-small Cell Lung Cancer

Disclaimer

Manuscripts that are “Published at Acceptance” have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear prior to being copy edited or formatted in the style guide of this Journal. The contents of the manuscript may change before it is published in its final form. While accepted manuscripts are not yet assigned a volume, issue, or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. Manuscripts in this section will be removed once they have been assigned to a volume and issue, but will still retain the DOI and date of e-publication.